KARTIK SIVARAAMAN: Open Payments
NPI 1962651026 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,126 in 51 payments from 22 companies in 2025. Trend: 2023 $4,544 · 2024 $604 · 2025 $1,126
Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $182 |
| ARGENX US, INC. | 6 | $175 |
| Celgene Corporation | 1 | $104 |
| LivaNova USA, Inc. | 1 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Lundbeck LLC | 3 | $53 |
| Aucta Pharmaceuticals, Inc. | 2 | $50 |
| Impel Pharmaceuticals LLC | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
Products named: VYVGART HYTRULO, ZEPOSIA, QULIPTA, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, UBRELVY, WAINUA, VYVGART, REXULTI.
Industry payments across VA — which companies pay providers there.
